We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears Ranbaxy U.S. Subsidiary of GMP Violations
FDA Clears Ranbaxy U.S. Subsidiary of GMP Violations
November 4, 2013
Ranbaxy enjoyed some good news when its U.S. subsidiary resolved FDA GMP violations resulting from a 2012 inspection.